Forteo (teriparatide), human parathyroid hormone for treating osteoporosis

January 2003

You will soon see prescriptions for Forteo (teriparatide), human parathyroid hormone for treating osteoporosis.

It's the first osteoporosis drug that actually stimulates new bone growth. Others just slow bone loss.

It appears to be more effective than other therapies. It reduces vertebral fracture risk by up to 65%.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote